Pretreatment nomogram to predict the risk of acute urinary retention after I-125 prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 3, 2011, Pages 737-744

  Roeloffzen, Ellen M ^a   Van Vulpen, Marco ^a   Battermann, Jan J ^a   Van Roermund, Joep G ^a   Saibishkumar, Elantholi P ^b   Monninkhof, Evelyn M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Acute urinary retention (AUR); Prediction nomogram; Prostate brachytherapy; Prostate cancer; Urinary toxicity

Indexed keywords

BASIC MODELS; HORMONAL TREATMENTS; INTERNATIONAL PROSTATE SYMPTOM SCORES; IODINE-125; MULTI VARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSIONS; PRE-TREATMENT; PREDICTIVE ABILITIES; PROSTATE BRACHYTHERAPY; PROSTATE CANCERS; PROSTATE VOLUME; QUALITY OF LIFE; RECEIVER OPERATOR CHARACTERISTICS; RISK FACTORS; URINARY RETENTION; URINARY TOXICITY;

CALIBRATION; DECISION MAKING; DISEASES; FORECASTING; IODINE; MULTIVARIANT ANALYSIS; NOMOGRAMS; ONCOLOGY; RADIOTHERAPY; REGRESSION ANALYSIS;

RISKS;

ACUTE URINARY RETENTION; AGED; ARTICLE; BRACHYTHERAPY; HUMAN; MAJOR CLINICAL STUDY; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; SCORING SYSTEM; URINE RETENTION;

AGED; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; DECISION MAKING; DISCRIMINANT ANALYSIS; HUMANS; IODINE RADIOISOTOPES; MALE; NOMOGRAMS; OBSERVER VARIATION; ORGAN SIZE; PROSTATE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; REGRESSION ANALYSIS; RISK ASSESSMENT; ROC CURVE; URINARY BLADDER; URINARY RETENTION;

EID: 80053611828     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.009     Document Type: Article

References (38)

1. K.A. Hinnen, J.J. Battermann, and J.G. van Roermund Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 76 2010 1433 1438
2. M.J. Zelefsky, D.A. Kuban, and L.B. Levy Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation Int J Radiat Oncol Biol Phys 67 2007 327 333 (Pubitemid 46108308)
3. L. Potters, C. Morgenstern, and E. Calugaru 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer J Urol 179 2008 S20 S24
4. E.M.A. Roeloffzen, I.M. Lips, and M.P.R. Gellekom Health-related quality of life up to six years after I-125 brachytherapy for localized prostate cancer Int J Radiot Oncol Biol Phys 76 2010 1054 1060
5. M.D. Terk, R.G. Stock, and N.N. Stone Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate J Urol 160 1998 1379 1382 (Pubitemid 29480520)
6. N. Lee, C.S. Wuu, and R. Brody Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 48 2000 1457 1460
7. J. Bucci, W.J. Morris, and M. Keyes Predictive factors of urinary retention following prostate brachytherapy Int J Radiat Oncol Biol Phys 53 2002 91 98 (Pubitemid 34465811)
8. J. Crook, M. McLean, and C. Catton Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation Int J Radiat Oncol Biol Phys 52 2002 453 460 (Pubitemid 34170850)
9. J. Locke, W. Ellis, and K. Wallner Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study Int J Radiat Oncol Biol Phys 52 2002 712 719 (Pubitemid 34158734)
10. M. Keyes, D. Schellenberg, and V. Moravan Decline in urinary retention incidence in 805 patients after prostate brachytherapy: The effect of learning curve? Int J Radiat Oncol Biol Phys 64 2006 825 834 (Pubitemid 43183581)
11. E.M.A. Roeloffzen, K.A. Hinnen, and J.J. Battermann The impact of acute urinary retention after I-125 prostate brachytherapy on health-related quality of life Int J Radiat Oncol Biol Phys 77 2010 1322 1328
12. A. Henderson, A.K. Ismail, and M. Cunningham Toxicity and early biochemical outcomes from 125iodine prostate brachytherapy in the UK. A prospective study Clin Oncol (R Coll Radiol) 16 2004 95 104 (Pubitemid 38344427)
13. M. Keyes, S. Miller, and V. Moravan Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: Long-term outcome in 712 consecutive patients Int J Radiat Oncol Biol Phys 73 2009 1023 1032
14. Roeloffzen EMA, Monninkhof EM, Battermann JJ, et al. Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate. Int J Radiat Oncol Biol Phys. In press.
15. D. Ash, A. Flynn, and J. Battermann ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer Radiother Oncol 57 2000 315 321
16. C. Salembier, P. Lavagnini, and P. Nickers Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy Radiother Oncol 83 2007 3 10 (Pubitemid 46527942)
17. J.J. Battermann, T.A. Boon, and M.A. Moerland Results of permanent prostate brachytherapy, 13 years of experience at a single institution Radiother Oncol 71 2004 23 28 (Pubitemid 38452898)
18. A. Trotti The evolution and application of toxicity criteria Semin Radiat Oncol 12 2002 1 3 (Pubitemid 34246061)
19. Frank E. Harrell Jr. Regression modeling strategies 2001 Springer Science & Business Media New York p. 57-60
20. P. Royston, K.G. Moons, D.G. Altman, and Y. Vergouwe Prognosis and prognostic research: Developing a prognostic model BMJ 338 2009 b604
21. E.W. Steyerberg, M.J. Eijkemans, F.E. Harrell Jr., and J.D. Habbema Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets Med Decis Making 21 2001 45 56 (Pubitemid 32245030)
22. M.J. Pencina, R.B. D'Agostino Sr, R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 (Pubitemid 351193639)
23. J.C. Van Houwelingen, and S. Le Cessie Predictive value of statistical models Stat Med 9 1990 1303 1325 (Pubitemid 20361741)
24. M. Keyes, S. Miller, and V. Moravan Urinary symptom flare in 712 125I prostate brachytherapy patients: Long-term follow-up Int J Radiat Oncol Biol Phys 75 2009 649 655
25. J. Crook, N. Fleshner, C. Roberts, and G. Pond Long-term urinary sequelae following 125iodine prostate brachytherapy J Urol 179 2008 141 145
26. K. Kelly, R. Swindell, and J. Routledge Prediction of urinary symptoms after 125iodine prostate brachytherapy Clin Oncol (R Coll Radiol) 18 2006 326 332
27. Roeloffzen EMA, Battermann JJ, Van Deursen MJH, et al. The influence of dose on the risk of acute urinary retention after I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. In press.
28. L. Eapen, C. Kayser, and Y. Deshaies Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity Int J Radiat Oncol Biol Phys 59 2004 1392 1394 (Pubitemid 38960765)
29. S.J. Buskirk, D.M. Pinkstaff, and S.P. Petrou Acute urinary retention after transperineal template-guided prostate biopsy Int J Radiat Oncol Biol Phys 59 2004 1360 1366 (Pubitemid 38954058)
30. M.J. Steggerda, H.G. van der Poel, and L.M. Moonen An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: Bladder hotspot dose and prostate size are significant predictors Radiother Oncol 88 2008 108 114 (Pubitemid 351894940)
31. H.K. Lee, M.T. Adams, and Q. Shi Seed implant retention score predicts the risk of prolonged urinary retention after prostate brachytherapy Int J Radiat Oncol Biol Phys 76 2010 1445 1449
32. H. Lepor Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia Rev Urol 6 Suppl 9 2004 S3 S10
33. M.D. Thomas, R. Cormack, and C.M. Tempany Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy Int J Radiat Oncol Biol Phys 47 2000 905 908 (Pubitemid 30345586)
34. G.S. Merrick, W.M. Butler, and R.W. Galbreath Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy Urology 57 2001 524 529 (Pubitemid 32192985)
35. J. Crook, A. Toi, M. McLean, and G. Pond The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy Brachytherapy 1 2002 131 137 (Pubitemid 37356898)
36. R.C. van den Bergh, E.W. Steyerberg, and A. Khatami Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer 116 2010 1281 1290
37. R.C. van den Bergh, H. Vasarainen, and H.G. van der Poel Short-term outcomes of the prospective multicentre "Prostate Cancer Research International: Active Surveillance" study BJU Int 105 2010 956 962
38. G.M. Villeirs, and G.O. De Meerleer Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning Eur J Radiol 63 2007 361 368 (Pubitemid 47321042)